Outlook Therapeutics, Inc.
OTLK
$0.38
$0.038.92%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.06M | -13.29M | -20.15M | -46.36M | 17.38M |
| Total Depreciation and Amortization | 30.10K | 29.70K | 29.40K | 29.10K | 28.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.46M | -2.38M | 6.04M | 35.67M | -35.26M |
| Change in Net Operating Assets | -2.37M | 3.26M | 2.19M | -5.92M | 6.89M |
| Cash from Operations | -14.94M | -12.38M | -11.90M | -16.58M | -10.97M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 0.00 | 0.00 | 33.10M | -- |
| Total Debt Repaid | -- | -2.33M | -907.00K | -32.91M | -- |
| Issuance of Common Stock | 15.53M | 13.89M | 14.15M | 18.25M | 1.74M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 15.53M | 11.56M | 13.25M | 18.44M | 1.74M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 594.30K | -817.70K | 1.34M | 1.85M | -9.23M |